The FDA approved the emergency use of the AstraZeneca COVID-19 vaccine in the Philippines
This, as the COVID-19 vaccine jointly developed by AstraZeneca and Oxford University was the second one to be granted emergency use authorization in the country, next to Pfizer-BioNTech COVID-19 vaccine.
FDA Director-General Eric Domingo on Thursday announced that the FDA had granted an emergency use authorization for AstraZeneca COVID-19 vaccine in the Philippines.
During the day’s Laging Handa briefing, Domingo said that all conditions for an emergency use authorization were present, adding that the benefit of using the said vaccine “outweighs potential risk”.
“The interim data, taken in its entirety, showed an efficacy rate of 70% after the first dose. Tumataas ito pagkatapos bigyan ng second dose,” Domingo added.
AstraZeneca was one of the few COVID-19 vaccine developers that had received emergency use authorizations from stringent regulatory authorities (SRA) recognized by the World Health Organization (WHO), allowing its application to be expedited by the Food and Drug Administration.
According to the Food and Drug Administration, those with stringent regulatory authorities can be approved within 21 days.
It was last January 14 when the Food and Drug Administration approved the emergency use of the Pfizer-BioNTech COVID-19 vaccine in the country.